Biomarkers and pathways in autism spectrum disorder: An individual meta-analysis based on proteomic and metabolomic data
Authors:
- 3 October 2024
- journal article
- research article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 275 (8) , 2461-2477
Abstract
The utilization of biomarkers for the diagnosis and management of autism spectrum disorders (ASD) remains a relatively unexplored frontier in clinical practice. Proteomics and metabolomics are important tools for revealing key biomarkers and evaluating biological pathways in ASD. We conducted an individual meta-analysis to compare the consistency of biomarkers of ASD from central nervous system (brain and cerebrospinal fluid), circulatory system (blood), and non-invasive samples (urine, saliva, and faeces) and performed pathway enrichment analyses to identify pathways enriched in ASD. After screening 926 proteomics and 619 metabolomics articles, we collected data from 10 studies involving 940 differential proteins and 16 studies assessing a total of 748 differential metabolites. In brain tissue, blood, and urine of ASD cases and controls, flotillin-2 (FLOT2), apolipoprotein E (ApoE), and EH domain-containing protein 3 (EHD3) exhibit differential expression, while vinculin (VCL) displays variations in saliva, blood, and urine. Similarly, in case-control studies, gelsolin (GSN) shows differential expression in brain tissue, saliva, and urine, and malate dehydrogenase 2 (MDH2) in brain tissue, blood, and saliva. Hippuric acid and salicyluric acid were simultaneously found in the brain, blood, urine, and faeces. In terms of pathways, glycolysis/gluconeogenesis, carbon metabolism, and glutathione metabolism were enriched in the brain as well as in saliva or urine. In our study, we identified six shared protein and two metabolic markers in central nervous system, circulatory system, and non-invasive samples, underscoring their potential value for ASD diagnosis and management, warranting further research.Keywords
Funding Information
- Science Fund for Distinguished Young Scholars of Guangdong Province (2022B1515020094)
- China Medical Board (20389)
- Sunac Talent Support Programme, School of Public Health, Sun Yat-sen University
This publication has 87 references indexed in Scilit:
- Identification of Amino Acid Dysregulation as a Potential Biomarker for Autism Spectrum Disorder in ChinaNeurotoxicity Research, 2020
- iTRAQ‐Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with AutismProteomics – Clinical Applications, 2017
- The role of methionine on metabolism, oxidative stress, and diseasesAmino Acids, 2017
- Chronic Exposure to β-Alanine Generates Oxidative Stress and Alters Energy Metabolism in Cerebral Cortex and Cerebellum of Wistar RatsMolecular Neurobiology, 2017
- HIF‐1 at the crossroads of hypoxia, inflammation, and cancerInternational Journal of Cancer, 2015
- A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum DisorderAutism Research, 2015
- Taurine and inflammatory diseasesAmino Acids, 2012
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeBrain, Behavior, and Immunity, 2011
- Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )2010
- Neuroglial activation and neuroinflammation in the brain of patients with autismAnnals of Neurology, 2004